Topic
Pharmaceuticals
993 published works
Neal, Gerber & Eisenberg LLP
ACI’s 2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada
The life sciences industry continues to navigate significant legal and business developments across intellectual property, regulatory compliance, commercialization, and emerging technologies. Companies face increasing pressure to protect innovation while adapting…
Warner Norcross + Judd LLP
What Employers Need to Know About Pharmacy Benefit Managers
As pharmacy benefit manager transparency, costs and oversight receive increasing attention, employers that sponsor group health plans face greater expectations to understand how their pharmacy benefit programs are managed. With…
Freshfields News
Freshfields advises on the sale of HELM Pharmaceuticals to Noucor
By Freshfields
Global law firm Freshfields has advised HELM AG on the sale of its finished dosage form business, HELM Pharmaceuticals, to Noucor. HELM Pharmaceuticals has been developing finished dosage form products…
Inside EU Life Sciences
Germany Reviews a New Pharma “Location Clause” (Standortklausel) for Pricing & Reimbursement Incentives – Improvement or Worsening for the Pharmaceutical Industry?
By Dr. Dr. Adem Koyuncu, Maximilian Aretz
Hot off the press, yesterday evening, 29 September 2026, the German Government’s expert committee presented the eagerly awaited proposal for a new "location clause" (Standortklausel) to incentivize pharmaceutical R&D and…
HLC - All Publications
Pharmacy compounding under the EU pharma law package – What marketing authorisation holders and innovators need to know
By Cadwalader Wickersham & Taft
In 2023, the European Commission proposed the most significant reform of the EU pharmaceutical legislation in over 20 years, replacing Directive 2001/83/EC and Regulation (EC) No 726/2004. The legislative process…
India Legal
Supreme Court flags massive cancer drug markups, suggests 16% MRP cap
By Legal Desk
The Supreme Court on Tuesday questioned the Centre over the wide disparity between the price to retailer (PTR) and Maximum Retail Price (MRP) of cancer drugs and other medicines, asking…
International Trade Insights
CBP Releases Updated Section 232 Guidance for Pharmaceutical Articles and Ingredients
By Nithya Nagarajan, Bilal Hassan
On September 28, 2026, U.S. Customs and Border Protection (CBP) issued CSMS #70054007, providing updated guidance on the implementation of the Section 232 duties on imported pharmaceuticals and pharmaceutical ingredients…
India Legal
Supreme Court declines PIL on fake drug menace, directs authorities to consider plea
By Legal Desk
The Supreme Court on Tuesday declined to entertain a PIL raising concerns over the manufacture and sale of fake drugs, including counterfeit cancer and other life-saving medicines. However, the Court…
Neal, Gerber & Eisenberg LLP
Top Employer-Sponsored Healthcare Considerations for 2027: Key Insights for Benefits and HR Leaders
Healthcare and benefits leaders face a growing challenge: controlling costs while supporting employee well-being, improving outcomes and navigating an increasingly complex regulatory environment. As organizations prepare for 2027, employer-sponsored healthcare…
Big Molecule Watch
Dualitas Therapeutics and Roche Enter Research Collaboration to Discover and Develop Bispecific Antibodies
On September 17, 2026, Dualitas Therapeutics, Inc. (“Dualitas”) announced a research collaboration and license agreement with Roche to advance novel bispecific antibodies (“BsAbs”) for immunology and inflammation diseases, using Dualitas’…